This work was followed by nonhuman primate studies showing intravitreal VEGF inhibition prevented neovascularization in response to induced retinal ischemia, paving the way for future clinical studies using anti-VEGF agents in humans [20]. Here, VEGFA is linked to retinal ischemia.